La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), an investigational product to treat conditions characterized by iron overload. The company was founded in 1989 and is headquartered in San Diego, California.
Show more...
首席执行官
员工
59
国家
US
ISIN
US5034596040
WKN
000A1XB6B
上市
0 Comments
分享你的想法
FAQ
La Jolla Pharmaceutical 今天的股价是多少?▼
LJPC 当前价格为 $6.22 USD,过去 24 小时上涨了 +0%。在图表上更密切关注 La Jolla Pharmaceutical 股价表现。
La Jolla Pharmaceutical 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,La Jolla Pharmaceutical 的股票以代码 LJPC 进行交易。
La Jolla Pharmaceutical 的市值是多少?▼
今天 La Jolla Pharmaceutical 的市值为 170.98M
La Jolla Pharmaceutical 有多少名员工?▼
截至四月 01, 2026,公司共有59名员工。
La Jolla Pharmaceutical 属于哪个行业?▼
La Jolla Pharmaceutical从事于Manufacturing行业。
La Jolla Pharmaceutical 何时完成拆股?▼
La Jolla Pharmaceutical 上次拆股发生在 一月 14, 2014,比例为 1:50。